...
首页> 外文期刊>Cellular reprogramming >Chromatin-Modifying Agents Reactivate Embryonic Renal Stem/Progenitor Genes in Human Adult Kidney Epithelial Cells but Abrogate Dedifferentiation and Stemness
【24h】

Chromatin-Modifying Agents Reactivate Embryonic Renal Stem/Progenitor Genes in Human Adult Kidney Epithelial Cells but Abrogate Dedifferentiation and Stemness

机译:染色质修饰剂激活人类成年肾脏上皮细胞中的胚胎肾干/祖细胞基因,但消除了去分化和干性。

获取原文
获取原文并翻译 | 示例

摘要

Recent studies have suggested that epigenetic modulation with chromatin-modifying agents can induce stemness and dedifferentiation and increase developmental plasticity. For instance, valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, has been shown to promote self-renewal/expansion of hematopoietic stem cells and facilitate the generation of induced pluripotent stem cells (iPSCs). Previously, we observed that down-regulation of embryonic renal stem/progenitor genes in the adult kidney was associated, at least in part, with epigenetic silencing. Therefore, we hypothesized that VPA may alter the expression of these genes and reprogram mature human adult kidney epithelial cells (hKEpCs) to a stem/progenitor-like state. Here, using quantitative RT-PCR and flow cytometry [fluorescence-activated cell sorting (FACS)] analysis, we show in VPA-treated primary cultures of human adult and fetal kidney significant reinduction of the renal stem/progenitor markers SIX2, OSR1, SALL1, NCAM, and PSA-NCAM. Robust SIX2 mRNA re-expression was confirmed at the protein level by western blot and was associated with epigenetic changes of the histones at multiple sites of the SIX2 promoter leading to gene activation, significantly increased acetylation of histones H4, and methylation of lysine 4 on H3. Furthermore, we could demonstrate synergistic effects of VPA and Wnt antagonists on SIX2 and also OSR1 reinduction. Nevertheless, VPA resulted in upregulation of E-CADHERIN and reduction in VIMENTIN, preventing the skewing of hKEpCs towards a more replicative mesenchymal state required for clonogenic expansion and acquisition of stem cell characters, altogether inducing cell senescence at early passages. These results demonstrating that chromatin-modifying agents prevent dedifferentiation of hKEpCs have important clinical implications as they may limit ex-vivo self-renewal/expansion and possibly the in vivo renal regenerative capacity initiated by dedifferentiation.
机译:最近的研究表明,用染色质修饰剂进行表观遗传调节可以诱导茎干和去分化并增加发育可塑性。例如,已证明组蛋白脱乙酰基酶(HDAC)抑制剂丙戊酸(VPA)可以促进造血干细胞的自我更新/扩增,并促进诱导多能干细胞(iPSC)的生成。以前,我们观察到成年肾脏中胚胎肾干/祖基因的下调至少部分与表观遗传沉默有关。因此,我们假设VPA可能会改变这些基因的表达,并将成熟的成人肾上皮细胞(hKEpCs)重新编程为干/祖细胞样状态。在这里,使用定量RT-PCR和流式细胞术[荧光激活细胞分选(FACS)]分析,我们显示了在VPA处理的成人和胎儿肾脏的原代培养物中,肾干/祖细胞标记SIX2,OSR1,SALL1的显着还原,NCAM和PSA-NCAM。通过蛋白质印迹证实在蛋白质水平上鲁棒的SIX2 mRNA重新表达,并与SIX2启动子多个位点的组蛋白的表观遗传学改变相关,从而导致基因激活,组蛋白H4的乙酰化显着增加以及H3上赖氨酸4的甲基化。此外,我们可以证明VPA和Wnt拮抗剂对SIX2和OSR1还原的协同作用。然而,VPA导致E-CADHERIN的上调和VIMENTIN的减少,阻止了hKEpCs向克隆形成性扩张和获得干细胞特征所需的更具复制性的间充质状态倾斜,从而在早期传代时完全诱导了细胞衰老。这些结果表明,染色质修饰剂可防止hKEpCs脱分化,具有重要的临床意义,因为它们可能会限制离体自我更新/扩增,并可能限制由脱分化引发的体内肾脏再生能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号